Bicara Therapeutics Inc. (BCAX) Q2 2026 Earnings Call Transcript

Operator

Good day, and thank you for standing by. Welcome to the Bicara Therapeutics Second Quarter 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded.

I would now like to turn the conference over to your speaker for today, Rachel Frank. Please go ahead.

Rachel Frank
Vice President of Investor Relations and Corporate Communications

Thank you, and good morning, everyone. It’s a pleasure to welcome you to Bicara Therapeutics Second Quarter 2026 Earnings Call.

Earlier this morning, we issued a press release highlighting results from the quarter and provided a business update, including strategic leadership transitions marking the company’s next era of growth and execution. You can access the press release as well as the slides that we’ll be reviewing today by going to the Investors section of our company website.

Before we begin, please note that this call will include forward-looking statements under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Please refer to our most recent SEC filings for important risk factors that could cause our actual performance